RxDoctor Payments Data

David Williams, MD

Family Medicine · Belton, MONPI 1275528895

Payments from drug & device makers

$5,003in general payments, 2019–2025

Across 322 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$828
  • Novo Nordisk$675
  • Pfizer$386
  • Lilly USA, LLC$355
  • Boehringer Ingelheim$284
  • Abbott$227
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$4,989100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,003 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$37,489
Medicare patients
187
Services billed
416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin45$74,341
EliquisApixaban46$64,382
OzempicSemaglutide28$56,427
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$49,838
XareltoRivaroxaban36$35,166
MyrbetriqMirabegron18$23,533
JanuviaSitagliptin Phosphate22$22,831
TrulicityDulaglutide11$14,320
FarxigaDapagliflozin Propanediol19$11,920
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$8,561
Atorvastatin Calcium498$5,417
ArexvyRsvpref3 Antigen/As01e/Pf17$4,761
Omeprazole288$4,650
LantusInsulin Glargine,hum.Rec.Anlog15$4,119
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$4,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$284$74,34145 claims
PfizerEliquis$386$64,38246 claims
Novo NordiskOzempic$675$56,42728 claims
GSKTrelegy Ellipta, Arexvy$114$54,59971 claims
Johnson & JohnsonXarelto$178$35,16636 claims
Astellas Pharma US IncMyrbetriq$34$23,53318 claims
MerckJanuvia$224$22,83122 claims
Lilly USA, LLCTrulicity$355$14,32011 claims
AstraZenecaFarxiga$141$11,92019 claims
Sanofi-aventis U.S. LLCLantus$47$4,11915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Belton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →